Bradsaúde (SAUD3) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jul, 2026Executive summary
Net operating revenue rose 7.2% year-over-year in 1Q25 to R$590.5 million, with a stable member base of 8.9 million and a 5% increase in average ticket across all segments.
Adjusted EBITDA grew 11.7% year-over-year to R$226.1 million, with margin expanding to 38.3% from 36.8%.
Recurring net income increased 10.5% year-over-year to R$166.6 million, with EPS up 11.5%.
SME and Individual plans continue to drive growth, now representing 43% of consolidated revenue and 60% of contribution margin.
The company maintains a zero-debt, asset-light, high-margin business model, with strong ESG credentials and inclusion in major B3 indexes.
Financial highlights
Consolidated net revenue for the last twelve months reached R$2,310 million, up 6.5% year-over-year, with a 15% CAGR since IPO.
Adjusted EBITDA for the last twelve months was R$718 million, with margin up from 29.9% to 31.1%.
Recurring net income for the last twelve months was R$544.8 million, up 14.4%, and recurring net income per share reached R$0.999.
Dividend, IOC, and share buyback in 1Q25 totaled R$151 million, representing a 90% payout of net income.
Net cash position at R$1.04 billion at March 31, 2025.
Outlook and guidance
SME and Individual plans are expected to continue driving revenue growth, leveraging bancassurance and digital channels.
Margin expansion anticipated through efficiency gains, digital investments, and favorable product mix.
Technology CAPEX peaked in 2023–2024 and is expected to decline, with ongoing focus on digital initiatives.
Share buyback program of up to 10 million shares through August 2025.
Latest events from Bradsaúde
- Net income up 15% in 3Q24, with margin expansion and 100% payout to shareholders.SAUD3
Q3 20249 Jul 2026 - Net income was R$1.3B in 1Q26, with 13M+ members and major hospital and digital expansion.SAUD3
Q1 20268 Jul 2026 - Revenue up 5.3%, net income up 4.1%, 83% payout, and strong net cash with zero debt.SAUD3
Q4 20256 Jul 2026 - Record SME growth and margin expansion drove strong revenue and net income gains.SAUD3
Q3 20256 Jul 2026 - Net income up 18.1% YoY, record EBITDA margin, and robust SME-driven growth.SAUD3
Q2 20256 Jul 2026 - Revenue up 5.9%, net income R$539M, 97% payout, R$913M net cash, no debt.SAUD3
Q4 20242 Jul 2026 - 2Q24 delivered strong growth, record margins, and a 100% net income payout to shareholders.SAUD3
Q2 20242 Jul 2026 - High-margin, tech-focused dental insurer grows SME segment, sustains top dividends, and zero debt.SAUD3
Status update28 Jan 2026